计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab177875-100μg |
100μg |
现货 ![]() |
| |
| Ab177875-1mg |
1mg |
现货 ![]() |
| |
| Ab177875-5mg |
5mg |
现货 ![]() |
| |
| Ab177875-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | JNJ-69086420 (anti-KLK2) |
|---|---|
| 别名 | JNJ-69086420(抗 KLK2) |
| 英文别名 | EC 3.4.21.35 | Glandular kallikrein-1 | hGK-1 | Tissue kallikrein-2 |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | KLK2 |
| 种属反应性 | 人(Human),食蟹猴(Cynomolgus monkey) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 26.5 kDa (Light Chain) & 50.5 kDa (Heavy Chain), under reducing conditions; 181.6 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
JNJ-69086420 (anti-KLK2) (Ab177875) - SEC
The purity of JNJ-69086420 (anti-KLK2) (Ab177875) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab177875 | |
| 分析证书 | Ab177875 | |
| 分析证书 | Ab177875 | |
| 分析证书 | Ab177875 | |
| 分析证书 | Ab177875 | |
| 分析证书 | Ab177875 |
| 1. Pakkala M, Hekim C, Soininen P, Leinonen J, Koistinen H, Weisell J, Stenman UH, Vepsäläinen J, Närvänen A. (2007) Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors.. J Pept Sci, 13 (5): (348-53). [PMID:17436344] |
| 2. Hekim C, Leinonen J, Närvänen A, Koistinen H, Zhu L, Koivunen E, Väisänen V, Stenman UH. (2006) Novel peptide inhibitors of human kallikrein 2.. J Biol Chem, 281 (18): (12555-60). [PMID:16527822] |
| 3. Santos JA, Kondo MY, Freitas RF, dos Santos MH, Ramalho TC, Assis DM, Juliano L, Juliano MA, Puzer L.. (2016) The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins.. Bioorg Med Chem Lett, 26 (5): (1485-1489). [PMID:26848109] [10.1016/j.bmcl.2016.01.039] |
| 4. Riegman, P H PH, Vlietstra, R J RJ, van der Korput, H A HA, Romijn, J C JC and Trapman, J J.. (1991) Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species.. Molecular and cellular endocrinology, [PMID:1726490] |
| 5. Schedlich, L J LJ, Bennetts, B H BH and Morris, B J BJ.. (1987) Primary structure of a human glandular kallikrein gene.. DNA (Mary Ann Liebert, Inc.), [PMID:2824146] |
| 6. Liu, X F XF, Essand, M M, Vasmatzis, G G, Lee, B B and Pastan, I I.. (1999) Identification of three new alternate human kallikrein 2 transcripts: evidence of long transcript and alternative splicing.. Biochemical and biophysical research communications, (2): [PMID:10544017] |
| 7. Gan, L L and 8 more authors.. (2000) Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region.. Gene, (17): [PMID:11054574] |
| 8. Hillman, R Tyler RT, Green, Richard E RE and Brenner, Steven E SE.. (2004) An unappreciated role for RNA surveillance.. Genome biology, [PMID:14759258] |
| 9. Cargill, M M and 17 more authors.. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes.. Nature genetics, [PMID:10391209] |